Group sales increased by 4,3 % up to EUR 673.1 mill. – preliminary Group-EBIT amounts to EUR 22.4 mill.

Group sales plus 4 % compared to previous year’s period

Change in the Supervisory Board of MEDICLIN

Significant sales increase in all segements

Ulf Ludwig will resign from the Board of Management

MEDICLIN startet well into the FY 2019

MEDICLIN will continue to grow – about 50 Millionen Euros will be invested

MEDICLIN increased its Group sales by about 6 % - Preliminary Group EBIT amounts to EUR 15.1 mill.

Ad hoc-Release Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014: Preliminary Group EBIT mainly burdened by one-off effects – preliminary Group sales meets forecast

MEDICLIN is satisfied with the business development of the first nine months of 2018